Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 22 results.
User Information
Export Records
  1. 1.   RAP uses a histidine switch to regulate its interaction with LRP in the ER and Golgi
  2. Lee, D.; Walsh, J. D.; Mikhailenko, I.; Yu, P.; Migliorini, M.; Wu, Y. B.; Krueger, S.; Curtis, J. E.; Harris, B.; Lockett, S.; Blacklow, S. C.; Strickl, D. K.; Wang, Y. X.
  3. Molecular Cell. 2006, MAY 5; 22(3): 423-430.
  1. 2.   Distribution of Epstein-Barr viral load in serum of individuals from nasopharyngeal carcinoma high-risk families in Taiwan
  2. Yang, X. H. R.; Goldstein, A. M.; Chen, C. J.; Rabkin, C. S.; Chen, J. Y.; Cheng, Y. J.; Hsu, W. L.; Sun, B.; Diehl, S. R.; Liu, M. Y.; Walters, M.; Shao, W.; Ortiz-Conde, B. A.; Whitby, D.; Elmore, S. H.; Gulley, M. L.; Hildesheim, A.
  3. International Journal of Cancer. 2006, MAR 1; 118(3): 780-784.
  1. 3.   Structural insight into the mechanism of double-stranded RNA processing by ribonuclease III
  2. Gan, J. H.; Tropea, J. E.; Austin, B. P.; Court, D. L.; Waugh, D. S.; Ji, X. H.
  3. Cell. 2006, JAN 27; 124(2): 355-366.
  1. 4.   Combining proteasome inhibition with TNF-related apoptosis-inducing ligand (Apo2L/TRAIL) for cancer therapy
  2. Sayers, T. J.; Murphy, W. J.
  3. Cancer Immunology Immunotherapy. 2006, JAN; 55(1): 76-84.
  1. 5.   The immunopharmacological properties of transforming growth factor beta
  2. Le, Y. Y.; Yu, X. J.; Ruan, L. F.; Wang, O. M.; Qi, D. F.; Zhu, J. J.; Lu, X. F.; Kong, Y.; Cai, K.; Pang, S. S.; Shi, X. L.; Wang, J. M.
  3. International Immunopharmacology. 2005, DEC; 5(13-14): 1771-1782.
  1. 6.   Plasmid partition system of the P1par family from the pWR100 virulence plasmid of Shigella flexneri
  2. Sergueev, K.; Dabrazhynetskaya, A.; Austin, S.
  3. Journal of Bacteriology. 2005, MAY; 187(10): 3369-3373.
  1. 7.   Substrate-induced conformational changes in glycosyltransferases
  2. Qasba, P. K.; Ramakrishnan, B.; Boeggeman, E.
  3. Trends in Biochemical Sciences. 2005, JAN; 30(1): 53-62.
  1. 8.   Expression and evaluation of RING finger proteins
  2. Yang, Y. L.; Lorick, K. L.; Jensen, J. P.; Weissman, A. M.
  3. Methods in Enzymology. 2005; 398 : 103-112.
  1. 9.   Single haplotype analysis demonstrates rapid evolution of the killer immunoglobulin-like receptor (KIR) loci in primates
  2. Sambrook, J. G.; Bashirova, A.; Palmer, S.; Sims, S.; Trowsdale, J.; bi-Rached, L.; Parham, P.; Carrington, M.; Beck, S.
  3. Genome Research. 2005, JAN; 15(1): 25-35.
  1. 10.   Birt-Hogg-Dube syndrome, a genodermatosis that increases risk for renal carcinoma
  2. Schmidt, L. S.
  3. Current Molecular Medicine. 2004, DEC; 4(8): 877-885.
  1. 11.   Tumor endothelial markers: new targets for cancer therapy
  2. Nanda, A.; St Croix, B.
  3. Current Opinion in Oncology. 2004, JAN; 16(1): 44-49.
  1. 12.   Unlocking the code of 14-3-3
  2. Dougherty, M. K.; Morrison, D. K.
  3. Journal of Cell Science. 2004 117(10): 1875-1884.
  1. 13.   Identification of a novel conserved motif in the STAT family that is required for tyrosine phosphorylation
  2. Gamero, A. M.; Sakamoto, S.; Montenegro, J.; Larner, A. C.
  3. Journal of Biological Chemistry. 2004 279(13): 12379-12385.
  1. 14.   Inhibition of growth by p205: A nuclear protein and putative tumor suppressor expressed during myeloid cell differentiation
  2. Dermott, J. M.; Gooya, J. M.; Asefa, B.; Weiler, S. R.; Smith, M.; Keller, J. R.
  3. Stem Cells. 2004 22(5): 832-848.
  1. 15.   Bayesian analysis for cystic fibrosis risks in prenatal and carrier screening
  2. Ogino, S.; Wilson, R. B.; Gold, B.; Hawley, P.; Grody, W. W.
  3. Genetics in Medicine. 2004, SEP-OCT; 6(5): 439-449.
  1. 16.   Bax deficiency partially corrects interleukin-7 receptor alpha deficiency
  2. Khaled, A. R.; Li, W. Q.; Huang, J. Q.; Fry, T. J.; Khaled, A. S.; Mackall, C. L.; Muegge, K.; Young, H. A.; Durum, S. K.
  3. Immunity. 2002 17(5): 561-573.
  1. 17.   An ATF2-derived peptide sensitizes melanomas to apoptosis and inhibits their growth and metastasis
  2. Bhoumik, A.; Huang, T. G.; Ivanov, V.; Gangi, L.; Qiao, R. F.; Woo, S. L. C.; Chen, S. H.; Ronai, Z.
  3. Journal of Clinical Investigation. 2002 110(5): 643-650.
  1. 18.   Similarities and differences between human and murine TNF promoters in their response to lipopolysaccharide
  2. Kuprash, D. V.; Udalova, I. A.; Turetskaya, R. L.; Kwiatkowski, D.; Rice, N. R.; Nedospasov, S. A.
  3. Journal of Immunology. 1999 162(7): 4045-4052.
  1. 19.   Lyn is activated during late G(1) of stem-cell-factor-induced cell cycle progression in haemopoietic cells
  2. Mou, S.; Linnekin, D.
  3. Biochemical Journal. 1999 342(Part 1): 163-170.
  1. 20.   Autocrine signals control CCAAT enhancer binding protein beta expression, localization, and activity in macrophages
  2. Baer, M.; Williams, S. C.; Dillner, A.; Schwartz, R. C.; Johnson, P. F.
  3. Blood. 1998 92(11): 4353-4365.
  1. 21.   Degradation of proto-oncoprotein c-Rel by the ubiquitin-proteasome pathway
  2. Chen, E.; Hrdlickova, R.; Nehyba, J.; Longo, D. L.; Bose, H. R.; Li, C. C. H.
  3. Journal of Biological Chemistry. 1998 273(52): 35201-35207.
  1. 22.   C/Ebp-Epsilon Is a Myeloid-Specific Activator of Cytokine, Chemokine, and Macrophage-Colony-Stimulating Factor Receptor Genes
  2. Williams, S. C.; Du, Y.; Schwartz, R. C.; Weiler, S. R.; Ortiz, M.; Keller, J. R.; Johnson, P. F.
  3. Journal of Biological Chemistry. 1998 273(22): 13493-13501.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel